Cassava Sciences, Inc. (SAVA)

Cassava Sciences Market Cap

Cassava Sciences has a market cap or net worth of $483.60 million as of July 22, 2024. Its market cap has decreased by -49.44% in one year.

• Market Cap: 483.60M
• Enterprise Value: 359.43M
• 1-Year Change: -49.44%
• Ranking: #3033
• Category: Small-Cap
• Stock Price: $10.08

Market Cap Chart

Since July 14, 2000, Cassava Sciences's market cap has decreased from $565.10M to $483.60M, a decrease of -14.42%. That is a compound annual growth rate of -0.65%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	483.60M	-49.06%
Dec 29, 2023	949.30M	-19.80%
Dec 30, 2022	1.18B	-32.32%
Dec 31, 2021	1.75B	902.69%
Dec 31, 2020	174.40M	94.86%
Dec 31, 2019	89.50M	513.01%
Dec 31, 2018	14.60M	-44.70%
Dec 29, 2017	26.40M	0.38%
Dec 30, 2016	26.30M	-67.17%
Dec 31, 2015	80.10M	-13.78%
Dec 31, 2014	92.90M	-57.93%
Dec 31, 2013	220.80M	80.84%
Dec 31, 2012	122.10M	-28.01%
Dec 30, 2011	169.60M	-41.19%
Dec 31, 2010	288.40M	27.44%
Dec 31, 2009	226.30M	-8.97%
Dec 31, 2008	248.60M	-46.82%
Dec 31, 2007	467.50M	18.81%
Dec 29, 2006	393.50M	32.67%
Dec 30, 2005	296.60M	-5.66%
Dec 31, 2004	314.40M	28.01%
Dec 31, 2003	245.60M	277.85%
Dec 31, 2002	65.00M	-73.54%
Dec 31, 2001	245.70M	-38.20%
Dec 29, 2000	397.60M	-29.64%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Treace Medical Concepts	488.62M
Eliem Therapeutics	487.53M
Fate Therapeutics	486.06M
biote	485.75M
Third Harmonic Bio	483.61M
Enhabit	475.98M
Theravance Biopharma	465.42M
Anavex Life Sciences	463.84M